NCT07067268 2025-07-16
Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy
Fudan University
Phase 2 Recruiting
Clinical Trials
3 trialsNCT04517214 2025-04-02
Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma
Fudan University
Phase 2 Active not recruiting
NCT01694576 2015-06-15
NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent Chemoradiation
Jiangsu Cancer Institute & Hospital
Phase 2 Terminated